579 related articles for article (PubMed ID: 29394499)
1. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.
Huang S; Frangogiannis NG
Br J Pharmacol; 2018 May; 175(9):1377-1400. PubMed ID: 29394499
[TBL] [Abstract][Full Text] [Related]
2. New Therapies to Modulate Post-Infarction Inflammatory Alterations in the Myocardium: State of the Art and Forthcoming Applications.
Clerc OF; Haaf P; Buechel RR; Gaemperli O; Zellweger MJ
Curr Radiopharm; 2021; 14(3):273-299. PubMed ID: 33302861
[TBL] [Abstract][Full Text] [Related]
3. Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.
Saxena A; Russo I; Frangogiannis NG
Transl Res; 2016 Jan; 167(1):152-66. PubMed ID: 26241027
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition.
Panahi M; Papanikolaou A; Torabi A; Zhang JG; Khan H; Vazir A; Hasham MG; Cleland JGF; Rosenthal NA; Harding SE; Sattler S
Cardiovasc Res; 2018 Sep; 114(11):1445-1461. PubMed ID: 30010800
[TBL] [Abstract][Full Text] [Related]
5. Targeting inflammatory pathways in myocardial infarction.
Christia P; Frangogiannis NG
Eur J Clin Invest; 2013 Sep; 43(9):986-95. PubMed ID: 23772948
[TBL] [Abstract][Full Text] [Related]
6. Repair of the Infarcted Heart: Cellular Effectors, Molecular Mechanisms and Therapeutic Opportunities.
Hilgendorf I; Frantz S; Frangogiannis NG
Circ Res; 2024 Jun; 134(12):1718-1751. PubMed ID: 38843294
[TBL] [Abstract][Full Text] [Related]
7. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.
Ong SB; Hernández-Reséndiz S; Crespo-Avilan GE; Mukhametshina RT; Kwek XY; Cabrera-Fuentes HA; Hausenloy DJ
Pharmacol Ther; 2018 Jun; 186():73-87. PubMed ID: 29330085
[TBL] [Abstract][Full Text] [Related]
8. The inflammatory response in myocardial injury, repair, and remodelling.
Frangogiannis NG
Nat Rev Cardiol; 2014 May; 11(5):255-65. PubMed ID: 24663091
[TBL] [Abstract][Full Text] [Related]
9. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.
Prabhu SD; Frangogiannis NG
Circ Res; 2016 Jun; 119(1):91-112. PubMed ID: 27340270
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and left ventricular remodelling after myocardial infarction.
Hori M; Nishida K
Cardiovasc Res; 2009 Feb; 81(3):457-64. PubMed ID: 19047340
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure.
Hanna A; Frangogiannis NG
Cardiovasc Drugs Ther; 2020 Dec; 34(6):849-863. PubMed ID: 32902739
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing.
Kempf T; Zarbock A; Vestweber D; Wollert KC
J Mol Med (Berl); 2012 Apr; 90(4):361-9. PubMed ID: 22228177
[TBL] [Abstract][Full Text] [Related]
13. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.
Andreadou I; Cabrera-Fuentes HA; Devaux Y; Frangogiannis NG; Frantz S; Guzik T; Liehn EA; Gomes CPC; Schulz R; Hausenloy DJ
Cardiovasc Res; 2019 Jun; 115(7):1117-1130. PubMed ID: 30825305
[TBL] [Abstract][Full Text] [Related]
14. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities.
Frangogiannis NG
J Cardiovasc Pharmacol; 2014 Mar; 63(3):185-95. PubMed ID: 24072174
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis after acute myocardial infarction.
Wu X; Reboll MR; Korf-Klingebiel M; Wollert KC
Cardiovasc Res; 2021 Apr; 117(5):1257-1273. PubMed ID: 33063086
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture.
Gao XM; Tsai A; Al-Sharea A; Su Y; Moore S; Han LP; Kiriazis H; Dart AM; Murphy AJ; Du XJ
Cardiovasc Drugs Ther; 2017 Apr; 31(2):145-156. PubMed ID: 28204966
[TBL] [Abstract][Full Text] [Related]
17. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.
Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X
Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176
[TBL] [Abstract][Full Text] [Related]
18. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR.
Krishnamurthy P; Rajasingh J; Lambers E; Qin G; Losordo DW; Kishore R
Circ Res; 2009 Jan; 104(2):e9-18. PubMed ID: 19096025
[TBL] [Abstract][Full Text] [Related]
19. Chemokines in Myocardial Infarction.
Chen B; Frangogiannis NG
J Cardiovasc Transl Res; 2021 Feb; 14(1):35-52. PubMed ID: 32415537
[TBL] [Abstract][Full Text] [Related]
20. Targeting the chemokines in cardiac repair.
Cavalera M; Frangogiannis NG
Curr Pharm Des; 2014; 20(12):1971-9. PubMed ID: 23844733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
